Loading...
Loading...
LLY| Name | Value |
|---|---|
| Revenues | 11.4B |
| Cost of Revenue | 2.2B |
| Gross Profit | 9.3B |
| Operating Expense | 4.8B |
| Operating I/L | 4.4B |
| Other Income/Expense | -2.8B |
| Interest Income | 0.0B |
| Pretax | 1.6B |
| Income Tax Expense | 0.6B |
| Net Income/Loss | 1.0B |
Eli Lilly and Company is a global pharmaceutical company that specializes in the discovery, development, and marketing of a wide range of human pharmaceuticals. Its product portfolio includes medications for diabetes such as insulin lispro and Humulin, as well as treatments for cancer including Alimta, Cyramza, and Erbitux. Additionally, the company offers drugs for conditions like rheumatoid arthritis, psoriasis, migraine prevention, and erectile dysfunction. Eli Lilly also has a presence in the COVID-19 treatment space with Bamlanivimab and etesevimab, and Bebtelovimab. The company generates revenue through the sale of these pharmaceutical products and through collaborations with other biopharmaceutical companies.
